drugset / Trial / NCT00387725
Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Adolescents
RandomizedParallel-groupDouble-blindPrevention
Summary
Study to evaluate the safety of an investigational meningitis vaccine and the immune response to it in adolescents
Timeline
- Start
- 2006-11
- Primary completion
- 2008-01
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rLP2086 | Vaccine | 20 mg | — |
| Subject | rLP2086 | Vaccine | 60 mg | — |
| Subject | rLP2086 | Vaccine | 200 mg | — |
Indications
No indication recorded.